Holders over time
- THC
- ELV
| Quarter | THC | ELV |
|---|---|---|
| Q3 2020 | 4 holders, $722m | 30 holders, $15.0bn |
| Q4 2020 | 9 holders, $1.2bn | 29 holders, $16.7bn |
| Q1 2021 | 9 holders, $1.3bn | 25 holders, $18.6bn |
| Q2 2021 | 10 holders, $1.6bn | 30 holders, $19.4bn |
| Q3 2021 | 12 holders, $1.8bn | 26 holders, $18.5bn |
| Q4 2021 | 11 holders, $2.1bn | 29 holders, $23.3bn |
| Q1 2022 | 15 holders, $2.7bn | 31 holders, $23.9bn |
| Q2 2022 | 14 holders, $1.7bn | 32 holders, $23.3bn |
| Q3 2022 | 11 holders, $1.6bn | 34 holders, $22.6bn |
| Q4 2022 | 13 holders, $1.1bn | 34 holders, $25.5bn |
| Q1 2023 | 17 holders, $1.1bn | 39 holders, $22.5bn |
| Q2 2023 | 24 holders, $1.7bn | 38 holders, $20.6bn |
| Q3 2023 | 23 holders, $1.7bn | 34 holders, $19.8bn |
| Q4 2023 | 18 holders, $2.0bn | 36 holders, $20.3bn |
| Q1 2024 | 19 holders, $3.1bn | 35 holders, $21.3bn |
| Q2 2024 | 25 holders, $4.2bn | 33 holders, $22.1bn |
| Q3 2024 | 26 holders, $5.2bn | 30 holders, $20.2bn |
| Q4 2024 | 20 holders, $3.6bn | 32 holders, $15.9bn |
| Q1 2025 | 20 holders, $4.2bn | 28 holders, $17.1bn |
| Q2 2025 | 25 holders, $5.3bn | 27 holders, $14.8bn |
| Q3 2025 | 25 holders, $5.6bn | 27 holders, $12.7bn |
| Q4 2025 | 22 holders, $5.6bn | 25 holders, $17.0bn |
| Q1 2026 | 22 holders, $5.2bn | 26 holders, $13.6bn |
| Q2 2026 | 15 holders, $3.8bn | 28 holders, $17.7bn |
Tenet Healthcare Corp
- Holders
- 25
- Reported value
- $4.2bn
- Buyers
- 14
- Sellers
- 11
Breadth +3 among 94 comparable managers.
Elevance Health Inc Formerly
- Holders
- 33
- Reported value
- $22.1bn
- Buyers
- 14
- Sellers
- 21
Breadth -7 among 94 comparable managers.
Who holds both, Q2 2024
Both (14)
AQR Capital Management LLC, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, ExodusPoint Capital Management LP, Fidelity (FMR LLC), First Eagle Investment Management LLC, Glenview Capital Management LLC, Holocene Advisors LP, Invesco Ltd, Marshall Wace LLP, Millennium Management LLC, Point72 Asset Management LP, T. Rowe Price Associates Inc
Only THC (11)
Acadian Asset Management LLC, Citadel Advisors LLC, Farallon Capital Management LLC, Greenlight Capital, Harris Associates LP, Maverick Capital Ltd, Quantbot Technologies LP, Renaissance Technologies LLC, Schonfeld Strategic Advisors LLC, Walleye Capital LLC, Woodline Partners LP
Only ELV (19)
AllianceBernstein LP, Artisan Partners LP, Baillie Gifford & Co, Balyasny Asset Management LLC, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, Eisler Capital Management Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, MFS Investment Management, Moore Capital Management LP, Neuberger Berman Group LLC, Ruane Cunniff & Goldfarb LP, Two Sigma Investments LP, Voloridge Investment Management LLC, Wellington Management Group LLP, Winton Group Ltd
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.